These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Regulation of Adipogenesis and Lipid Deposits by Collapsin Response Mediator Protein 2. Chang YH; Tsai JN; Chang SW; Hsu WT; Yang CP; Hsiao CW; Shiau MY Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245267 [TBL] [Abstract][Full Text] [Related]
46. Changes in the expression of collapsin response mediator protein-2 during synaptic plasticity in the mouse hippocampus. Kadoyama K; Matsuura K; Nakamura-Hirota T; Takano M; Otani M; Matsuyama S J Neurosci Res; 2015 Nov; 93(11):1684-92. PubMed ID: 26250894 [TBL] [Abstract][Full Text] [Related]
47. Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration. Varrin-Doyer M; Vincent P; Cavagna S; Auvergnon N; Noraz N; Rogemond V; Honnorat J; Moradi-Améli M; Giraudon P J Biol Chem; 2009 May; 284(19):13265-76. PubMed ID: 19276087 [TBL] [Abstract][Full Text] [Related]
52. CRMP2 as a Candidate Target to Interfere with Lung Cancer Cell Migration. Morales X; Peláez R; Garasa S; Ortiz de Solórzano C; Rouzaut A Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680167 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A. Numata-Uematsu Y; Wakatsuki S; Nagano S; Shibata M; Sakai K; Ichinohe N; Mikoshiba K; Ohshima T; Yamashita N; Goshima Y; Araki T Neurosci Res; 2019 Feb; 139():63-68. PubMed ID: 30194029 [TBL] [Abstract][Full Text] [Related]
54. Peroxiredoxin interaction with the cytoskeletal-regulatory protein CRMP2: Investigation of a putative redox relay. Pace PE; Peskin AV; Konigstorfer A; Jasoni CJ; Winterbourn CC; Hampton MB Free Radic Biol Med; 2018 Dec; 129():383-393. PubMed ID: 30315937 [TBL] [Abstract][Full Text] [Related]
55. Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau. Hensley K; Kursula P J Alzheimers Dis; 2016 Apr; 53(1):1-14. PubMed ID: 27079722 [TBL] [Abstract][Full Text] [Related]
56. CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK. Lin B; Li Y; Wang T; Qiu Y; Chen Z; Zhao K; Lu N Oncogene; 2020 Sep; 39(37):6024-6040. PubMed ID: 32778769 [TBL] [Abstract][Full Text] [Related]
57. Isolation and expression pattern of human Unc-33-like phosphoprotein 6/collapsin response mediator protein 5 (Ulip6/CRMP5): coexistence with Ulip2/CRMP2 in Sema3a- sensitive oligodendrocytes. Ricard D; Rogemond V; Charrier E; Aguera M; Bagnard D; Belin MF; Thomasset N; Honnorat J J Neurosci; 2001 Sep; 21(18):7203-14. PubMed ID: 11549731 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief. Moutal A; Shan Z; Miranda VG; François-Moutal L; Madura CL; Khanna M; Khanna R Channels (Austin); 2019 Dec; 13(1):498-504. PubMed ID: 31680630 [TBL] [Abstract][Full Text] [Related]